IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Reminds Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 22, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Esperion Therapeutics, Inc. (“Esperion” or ”the Company”) (NASDAQ: ESPR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between February 22, 2017, and May 1, 2018, inclusive (the ”Class Period”), are encouraged to contact the firm before July 6, 2018.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, Esperion Therapeutics made materially false and misleading statements during the class period. Esperion failed to disclose that Bempedoic acid, the company’s cholesterol-lowering medication, had serious safety risks up to and including death. As a result of the failure to disclose this information, Esperion Therapeutics’ financial statements, claims about the company’s business operations, and financial prospects were materially false and misleading throughout the class period. According to the lawsuit, when accurate information about Esperion Therapeutics became apparent in the market, investors suffered damages.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
Sherin Mahdavian, Esq.
www.schallfirm.com

<p type="text" content="The Schall Law Firm
Brian Schall, Esq.
Sherin Mahdavian, Esq.
www.schallfirm.com“>SOURCE: The Schall Law Firm

ReleaseID: 503481